Ending TB: right dose, right time

Description:
TB is a treatable disease. Yet the rise of drug resistance means that even if people are correctly diagnosed, their chances of survival hinge on receiving the right treatment in a timely manner. Meanwhile, the only TB vaccine is over a century old and has limited applications.

FIND, TB Alliance, and IAVI are bringing together a panel of experts to review the tools we have in our hands today that have the potential to end TB for good, and what is needed to bring them to scale and achieve public health impact starting now.

Date and time: 11 April 2022 at 9:00 EDT | 15:00 CEST

Moderator:
David Lewinsohn, Research Working Groups Chair, Stop TB Partnership

Speakers:
Maria Beumont, Chief Medical Officer, TB Alliance
Sergio Carmona, Chief Medical Officer, FIND
Francesca Conradie, Researcher, Clinical HIV Research Unit, University of Witwatersrand
Robert Matiru, Director, Programme Division, Unitaid
Lewis Schrager, Senior Leader, Tuberculosis Impact Area, IAVI
Tina Shah, MDR-TB Survivor